Abstract
Nowadays, phage display libraries are used as robust tools for discovery and evolution of peptide/protein based drugs as well as targeting molecules, in particular monoclonal antibodies (mAbs) and its fragments (i.e., scFvs, Fabs, or bivalent F(ab′)2). Phage display technology, as a molecular diversity approach, enables selection of antibody fragments (e.g., scFv/Fab) with high affinity, specificity and effector functions against various targets. However, such selection process itself is largely dependent upon various molecular factors such as methods for construction of phage library, phage/phagemid vectors, helper phage, host cells and biopanning processes. The current review article provides important molecular considerations for successful development of phage antibody libraries that may be used as a platform for translation of antibody fragments into viable diagnostic/therapeutic reagents.
| Original language | English |
|---|---|
| Pages (from-to) | 195-208 |
| Number of pages | 14 |
| Journal | Journal of Drug Targeting |
| Volume | 20 |
| Issue number | 3 |
| DOIs | |
| State | Published - Apr 2012 |
| Externally published | Yes |
ASJC Scopus Subject Areas
- Pharmaceutical Science
Keywords
- Cancer
- Cancer targeting
- Drug targeting
- Monoclonal antibody
- Phage display
Fingerprint
Dive into the research topics of 'Molecular considerations for development of phage antibody libraries'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS